SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-06-12 17:17
Tx date 2023-06-07
$MIST
Milestone Pharmaceuticals Inc.
Wills, Robert James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
60,000
Filed 2023-06-12 17:16
Tx date 2023-06-07
$MIST
Milestone Pharmaceuticals Inc.
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
72,447
Filed 2023-06-12 17:15
Tx date 2023-06-07
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
64,000
Filed 2023-06-12 17:07
Tx date 2023-06-07
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
64,000
Filed 2023-06-12 17:04
Tx date 2023-06-07
$MIST
Milestone Pharmaceuticals Inc.
Giles, Lisa Masood
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
60,000
Filed 2023-06-12 17:02
Tx date 2023-06-07
$MIST
Milestone Pharmaceuticals Inc.
Fischer, Seth H.Z.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
72,000
Filed 2023-04-28 13:11
Tx date 2023-04-27
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,891
+5,500 vol
$3.80 each
133,386
Filed 2023-04-28 13:11
Tx date 2023-04-27
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$26,498
+7,000 vol
$3.79 each
127,886
Filed 2023-04-28 13:10
Tx date 2023-04-27
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,514
+5,500 vol
$3.73 each
120,886
Filed 2023-04-28 13:10
Tx date 2023-04-27
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$26,023
+7,000 vol
$3.72 each
115,386
Filed 2023-03-24 09:54
Tx date 2023-03-21
$MIST
Milestone Pharmaceuticals Inc.
Fischer, Seth H.Z.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+42,000 vol
42,000
Filed 2023-03-24 09:53
Tx date 2023-03-21
$MIST
Milestone Pharmaceuticals Inc.
Fischer, Seth H.Z.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-02-20 11:22
Tx date 2023-02-16
$MIST
Milestone Pharmaceuticals Inc.
Nelson, Jeffrey Edward
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+105,000 vol
710,100
Filed 2023-02-20 11:17
Tx date 2023-02-16
$MIST
Milestone Pharmaceuticals Inc.
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+130,000 vol
889,000
Filed 2023-02-20 11:13
Tx date 2023-02-16
$MIST
Milestone Pharmaceuticals Inc.
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+185,000 vol
515,000
Filed 2023-02-20 11:10
Tx date 2023-02-16
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+360,000 vol
2,579,061
Filed 2023-02-20 11:08
Tx date 2023-02-16
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+105,000 vol
661,456
Filed 2022-12-05 12:59
Tx date 2022-12-05
$MIST
Milestone Pharmaceuticals Inc.
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$32,830
+7,000 vol
$4.69 each
10,000
Filed 2022-12-05 09:32
Tx date 2022-12-01
$MIST
Milestone Pharmaceuticals Inc.
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,580
+3,000 vol
$4.86 each
3,000
Filed 2022-12-05 09:32
Tx date 2022-02-15
$MIST
Milestone Pharmaceuticals Inc.
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-10-21 21:44
Tx date 2022-10-21
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez Family Trust (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$21,040
+4,000 vol
$5.26 each
4,000
Filed 2022-10-21 21:43
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez Family Trust (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-10-21 21:42
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,144
+600 vol
$5.24 each
10,000
Filed 2022-10-21 21:41
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,108
+400 vol
$5.27 each
9,400
Filed 2022-10-21 21:41
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$236.70
+45 vol
$5.26 each
9,000
Filed 2022-10-21 21:41
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$14,018
+2,655 vol
$5.28 each
8,955
Filed 2022-10-21 21:41
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$555.45
+105 vol
$5.29 each
6,300
Filed 2022-10-21 21:40
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$32,833
+6,195 vol
$5.30 each
6,195
Filed 2022-10-21 21:39
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Holder: The Rodriguez and Liebert Revocable Trust (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-10-21 21:38
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,144
+600 vol
$5.24 each
Filed 2022-10-21 21:38
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,108
+400 vol
$5.27 each
Filed 2022-10-21 21:37
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$236.70
+45 vol
$5.26 each
Filed 2022-10-21 21:37
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,018
+2,655 vol
$5.28 each
Filed 2022-10-21 21:37
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$555.45
+105 vol
$5.29 each
Filed 2022-10-21 21:37
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$32,833
+6,195 vol
$5.30 each
Filed 2022-10-21 12:02
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,013
+200 vol
$5.07 each
10,000
Filed 2022-10-21 12:01
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,551
+300 vol
$5.17 each
9,800
Filed 2022-10-21 12:01
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,876
+368 vol
$5.10 each
9,500
Filed 2022-10-21 12:01
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,536
+300 vol
$5.12 each
9,132
Filed 2022-10-21 12:00
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$516.00
+100 vol
$5.16 each
8,832
Filed 2022-10-21 12:00
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,577
+700 vol
$5.11 each
8,732
Filed 2022-10-21 12:00
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,006
+1,732 vol
$5.20 each
8,032
Filed 2022-10-21 11:59
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,626
+700 vol
$5.18 each
6,300
Filed 2022-10-21 11:59
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$29,344
+5,600 vol
$5.24 each
5,600
Filed 2022-10-21 11:59
Tx date 2019-11-11
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,144
+600 vol
$5.24 each
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,144
+600 vol
$5.24 each
10,127
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,108
+400 vol
$5.27 each
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,108
+400 vol
$5.27 each
9,527
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$236.70
+45 vol
$5.26 each
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$236.70
+45 vol
$5.26 each
9,127
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,018
+2,655 vol
$5.28 each
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,018
+2,655 vol
$5.28 each
9,082
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$555.45
+105 vol
$5.29 each
Filed 2022-10-21 10:56
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$555.45
+105 vol
$5.29 each
6,427
Filed 2022-10-21 10:55
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$32,833
+6,195 vol
$5.30 each
Filed 2022-10-21 10:55
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$32,833
+6,195 vol
$5.30 each
6,322
Filed 2022-10-21 10:55
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$50,000
+10,000 vol
$5.00 each
Filed 2022-10-21 10:49
Tx date 2022-10-20
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$50,000
+10,000 vol
$5.00 each
Filed 2022-10-21 10:43
Tx date 2022-10-19
$MIST
Milestone Pharmaceuticals Inc.
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$79,857
+15,000 vol
$5.32 each
15,000
Filed 2022-10-19 16:21
Tx date 2022-10-19
$MIST
Milestone Pharmaceuticals Inc.
Wills, Robert James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$73,918
+15,000 vol
$4.93 each
15,000
Filed 2022-10-19 16:19
Tx date 2020-10-01
$MIST
Milestone Pharmaceuticals Inc.
Wills, Robert James
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-09-16 15:54
Tx date 2022-09-14
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
97 - Other

+127 vol
127
Filed 2022-08-25 16:06
Tx date 2022-08-16
$MIST
Milestone Pharmaceuticals Inc.
Nelson, Jeffrey Edward
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
605,100
Filed 2022-06-01 14:39
Tx date 2022-05-31
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$28,000
+5,000 vol
$5.60 each
81,780
Filed 2022-06-01 14:25
Tx date 2022-05-31
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$2,186
+822 vol
$2.66 each
76,780
Filed 2022-06-01 14:24
Tx date 2022-05-31
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$35,279
+22,870 vol
$1.54 each
75,958
Filed 2022-06-01 14:24
Tx date 2022-05-31
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$69,528
+45,072 vol
$1.54 each
53,088
Filed 2022-06-01 14:23
Tx date 2022-05-31
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,954
+8,016 vol
$1.12 each
8,016
Filed 2022-06-01 14:23
Tx date 2022-05-31
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-2,186.2734
-822 vol
$2.66 each
21,776
Filed 2022-06-01 14:22
Tx date 2022-05-31
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-35,279.262
-22,870 vol
$1.54 each
22,598
Filed 2022-06-01 14:21
Tx date 2022-05-31
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-69,528.0672
-45,072 vol
$1.54 each
45,468
Filed 2022-06-01 14:21
Tx date 2022-05-31
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-8,954.6736
-8,016 vol
$1.12 each
90,540
Filed 2022-03-24 10:35
Tx date 2022-03-21
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
2,219,061
Filed 2022-03-24 10:33
Tx date 2022-03-21
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+160,000 vol
556,456
Filed 2022-03-24 10:29
Tx date 2022-03-21
$MIST
Milestone Pharmaceuticals Inc.
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+175,000 vol
759,000
Filed 2022-02-16 20:53
Tx date 2022-02-15
$MIST
Milestone Pharmaceuticals Inc.
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+330,000 vol
330,000
Filed 2022-02-16 20:51
Tx date 2022-02-15
$MIST
Milestone Pharmaceuticals Inc.
Bharucha, David
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-29 12:01
Tx date 2021-03-24
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
396,456
Filed 2021-03-29 12:00
Tx date 2021-03-24
$MIST
Milestone Pharmaceuticals Inc.
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+240,000 vol
584,000
Filed 2021-03-29 11:58
Tx date 2021-03-24
$MIST
Milestone Pharmaceuticals Inc.
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+130,000 vol
474,146
Filed 2021-03-29 11:53
Tx date 2021-03-24
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+670,000 vol
1,719,061
Filed 2020-12-07 14:02
Tx date 2019-12-30
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,616
+299 vol
$15.44 each
3,936,826
Filed 2020-12-07 13:59
Tx date 2019-12-30
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$16,027
+1,034 vol
$15.50 each
3,936,527
Filed 2020-11-02 11:07
Tx date 2019-12-30
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,621
+1,333 vol
$15.47 each
Filed 2020-11-02 11:14
Tx date 2020-03-19
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$63,806
+5,870 vol
$10.87 each
4,315,102
Filed 2020-11-02 11:10
Tx date 2020-03-18
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$28,023
+2,705 vol
$10.36 each
4,309,232
Filed 2020-11-02 11:09
Tx date 2020-03-02
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,483,083
+78,263 vol
$18.95 each
4,306,527
Filed 2020-11-02 11:08
Tx date 2020-01-13
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,387,500
+270,000 vol
$16.25 each
4,228,264
Filed 2020-11-02 11:08
Tx date 2019-12-31
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$332,289
+21,438 vol
$15.50 each
3,958,264
Filed 2020-11-02 11:07
Tx date 2019-12-30
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,621
+1,333 vol
$15.47 each
3,936,826
Filed 2020-11-02 11:06
Tx date 2019-11-30
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,400,000
+400,000 vol
$16.00 each
3,935,493
Filed 2020-11-02 11:05
Tx date 2019-10-15
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,800
+1,100 vol
$18.00 each
3,535,493
Filed 2020-11-02 11:05
Tx date 2019-10-11
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$72,798
+4,208 vol
$17.30 each
3,534,393
Filed 2020-11-02 11:04
Tx date 2019-10-10
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,864
+179 vol
$16.00 each
3,530,185
Filed 2020-11-02 11:03
Tx date 2019-10-03
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$34,935
+1,908 vol
$18.31 each
3,530,006
Filed 2020-11-02 11:03
Tx date 2019-10-01
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$110,046
+6,242 vol
$17.63 each
3,528,098
Filed 2020-11-02 11:02
Tx date 2019-05-09
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,000,005
+666,667 vol
$15.00 each
3,521,856
Filed 2020-11-02 11:01
Tx date 2019-05-09
$MIST
Milestone Pharmaceuticals Inc.
RTW Investments L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,855,189
Filed 2020-10-02 17:20
Tx date 2020-10-01
$MIST
Milestone Pharmaceuticals Inc.
Wills, Robert James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
30,000
Filed 2020-10-02 17:20
Tx date 2020-10-01
$MIST
Milestone Pharmaceuticals Inc.
Wills, Robert James
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-02 17:18
Tx date 2020-10-01
$MIST
Milestone Pharmaceuticals Inc.
Giles, Lisa Masood
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
30,000
Filed 2020-10-02 17:17
Tx date 2020-10-01
$MIST
Milestone Pharmaceuticals Inc.
Giles, Lisa Masood
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-27 10:48
Tx date 2020-08-26
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,778
+5,700 vol
$1.54 each
108,386
Filed 2020-08-27 10:47
Tx date 2020-08-26
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-8,778
-5,700 vol
$1.54 each
196,456
Filed 2020-07-30 14:25
Tx date 2020-07-29
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,555,000
-500,000 vol
$11.11 each
2,254,920
Filed 2020-07-30 14:23
Tx date 2020-07-28
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-215,116.29
-19,863 vol
$10.83 each
2,754,920
Filed 2020-06-08 16:34
Tx date 2020-06-05
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+35,000 vol
202,156
Filed 2020-06-08 16:33
Tx date 2020-04-03
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options

+18,043 vol
102,686
Filed 2020-06-08 16:32
Tx date 2020-04-03
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-27,786.22
-18,043 vol
$1.54 each
167,156
Filed 2020-06-08 16:31
Tx date 2020-04-03
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options

+32,528 vol
84,643
Filed 2020-06-08 16:31
Tx date 2020-04-03
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-50,093.12
-32,528 vol
$1.54 each
185,199
Filed 2020-06-08 16:30
Tx date 2019-10-01
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options

+2,500 vol
52,115
Filed 2020-06-08 16:29
Tx date 2019-10-01
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-3,850
-2,500 vol
$1.54 each
157,727
Filed 2020-06-08 16:26
Tx date 2020-06-05
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
34,000
Filed 2020-06-08 16:24
Tx date 2020-06-05
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
98,556
Filed 2020-06-08 16:22
Tx date 2020-06-05
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
34,000
Filed 2020-06-08 16:20
Tx date 2020-06-05
$MIST
Milestone Pharmaceuticals Inc.
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
67,638
Filed 2020-06-08 16:18
Tx date 2020-06-05
$MIST
Milestone Pharmaceuticals Inc.
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
42,447
Filed 2020-06-08 16:15
Tx date 2020-06-05
$MIST
Milestone Pharmaceuticals Inc.
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+35,000 vol
344,146
Filed 2020-06-08 16:12
Tx date 2020-06-05
$MIST
Milestone Pharmaceuticals Inc.
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+115,000 vol
344,000
Filed 2020-06-08 16:02
Tx date 2020-06-05
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
1,049,061
Filed 2020-06-08 16:00
Tx date 2019-12-21
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options

+7,400 vol
280,555
Filed 2020-06-08 16:00
Tx date 2019-12-21
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-11,396
-7,400 vol
$1.54 each
699,061
Filed 2020-01-28 21:17
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+84,000 vol
309,146
Filed 2020-01-28 21:16
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+60,000 vol
220,227
Filed 2020-01-28 21:15
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
906,461
Filed 2020-01-28 21:14
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+82,000 vol
229,000
Filed 2020-01-28 07:50
Tx date 2020-01-27
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$59,361
+2,800 vol
$21.20 each
2,774,783
Filed 2020-01-27 12:09
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+60,000 vol
Filed 2020-01-27 12:08
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+82,000 vol
Filed 2020-01-27 12:06
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
Filed 2020-01-27 12:04
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+84,000 vol
Filed 2020-01-27 12:09
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+60,000 vol
220,227
Filed 2020-01-27 12:08
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+82,000 vol
229,000
Filed 2020-01-27 12:06
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
906,461
Filed 2020-01-27 12:04
Tx date 2020-01-23
$MIST
Milestone Pharmaceuticals Inc.
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+84,000 vol
309,146
Filed 2020-01-27 08:16
Tx date 2020-01-24
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$142,933
+6,949 vol
$20.57 each
2,771,983
Filed 2020-01-23 14:01
Tx date 2020-01-22
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$307,487
+15,161 vol
$20.28 each
2,765,034
Filed 2020-01-22 10:17
Tx date 2020-01-21
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$260,026
+13,703 vol
$18.98 each
2,749,873
Filed 2020-01-22 10:16
Tx date 2020-01-21
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$260,026
+13,703 vol
$18.98 each
Filed 2020-01-22 09:47
Tx date 2020-01-21
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$260,026
+13,703 vol
$18.98 each
2,749,873
Filed 2020-01-22 09:47
Tx date 2020-01-21
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$260,026
+13,703 vol
$18.98 each
Filed 2020-01-21 14:38
Tx date 2020-01-17
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$30,029
+1,625 vol
$18.48 each
2,736,170
Filed 2020-01-21 14:36
Tx date 2020-01-16
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$121,608
+6,600 vol
$18.43 each
2,734,545
Filed 2020-01-21 14:33
Tx date 2020-01-17
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$30,029
+1,625 vol
$18.48 each
Filed 2020-01-21 14:32
Tx date 2020-01-16
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$121,608
+6,600 vol
$18.43 each
Filed 2020-01-21 13:47
Tx date 2020-01-16
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$121,608
+6,600 vol
$18.43 each
Filed 2020-01-21 13:47
Tx date 2020-01-16
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$121,608
+6,600 vol
$18.43 each
2,734,545
Filed 2020-01-20 14:20
Tx date 2020-01-17
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$30,029
+1,625 vol
$18.48 each
Filed 2020-01-20 14:20
Tx date 2020-01-17
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$30,029
+1,625 vol
$18.48 each
2,729,570
Filed 2020-01-16 09:10
Tx date 2020-01-15
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$127,528
+7,000 vol
$18.22 each
2,727,945
Filed 2020-01-15 14:07
Tx date 2020-01-14
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,309
+635 vol
$17.81 each
2,720,945
Filed 2019-11-15 14:55
Tx date 2019-11-12
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+4,000 vol
83,556
Filed 2019-11-15 14:51
Tx date 2019-11-12
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+19,000 vol
19,000
Filed 2019-11-15 14:46
Tx date 2019-11-12
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+19,000 vol
19,000
Filed 2019-11-15 14:40
Tx date 2019-11-11
$MIST
Milestone Pharmaceuticals Inc.
Pasternak, Richard C.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-09-12 09:21
Tx date 2019-09-09
$MIST
Milestone Pharmaceuticals Inc.
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
104,596
Filed 2019-09-12 09:15
Tx date 2019-09-09
$MIST
Milestone Pharmaceuticals Inc.
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+147,000 vol
147,000
Filed 2019-09-12 09:13
Tx date 2019-09-09
$MIST
Milestone Pharmaceuticals Inc.
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-24 13:53
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
52,638
Filed 2019-05-22 16:35
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-23 09:29
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
51,640
Filed 2019-05-23 09:27
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:52
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:52
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
47,516
Filed 2019-05-22 16:51
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:50
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
84,596
Filed 2019-05-22 16:49
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:46
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:45
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Maness, Timothy Lee
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:44
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Kumar, Nilesh
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:44
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Kumar, Nilesh
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:43
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:43
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Liebert, Debra Kay
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:41
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Boorsma, Marco
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:41
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Boorsma, Marco
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:39
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
225,146
Filed 2019-05-22 16:39
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Plat, Francis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
11,456
Filed 2019-05-22 16:38
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
160,227
Filed 2019-05-22 16:37
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
49,615
Filed 2019-05-22 16:36
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
27,447
Filed 2019-05-22 16:36
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:35
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:34
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:34
Tx date 2019-04-10
$MIST
Milestone Pharmaceuticals Inc.
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:34
Tx date 2019-04-10
$MIST
Milestone Pharmaceuticals Inc.
Edick, Paul Raymond
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:33
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
706,461
Filed 2019-05-22 16:32
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
273,155
Filed 2019-05-22 16:31
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
79,556
Filed 2019-05-22 16:30
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:29
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
287,234
Filed 2019-05-22 16:28
Tx date 2019-05-13
$MIST
Milestone Pharmaceuticals Inc.
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:24
Tx date 2017-03-01
$MIST
Milestone Pharmaceuticals Inc.
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-22 16:21
Tx date 2017-03-01
$MIST
Milestone Pharmaceuticals Inc.
Douville, Philippe
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-17 08:35
Tx date 2019-05-09
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$8,753,326
+433,333 vol
$20.20 each
2,720,310
Filed 2019-05-17 08:31
Tx date 2019-05-09
$MIST
Milestone Pharmaceuticals Inc.
Fonds de solidarité FTQ
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,286,977